Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts

Transplantation

Volumn 69, Issue 2, 2000, Pages 214-221

  Nakano, Masahiko ^a,c   Yasunami, Yohichi ^a   Maki, Takanobu ^a   Kodama, Shouta ^a   Ikehara, Yasuto ^a   Nakamura, Toshikazu ^b   Tanaka, Masao ^c   Ikeda, Seiyo ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; HYPERGLYCEMIA; ISOGRAFT; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SURGICAL APPROACH; SURGICAL TECHNIQUE;

EID: 0034719348     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200001270-00004     Document Type: Conference Paper

References (45)

1. Scharp DW, Lacy PE, Santiago JV, et al. Insulin independence after islet transplantation into type I diabetic patient. Diabetes 1990; 39: 515.
2. Scharp DW, Lacy PE, Santiago JV, et al. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation 1991; 51: 76.
3. Warnock GL, Kneteman NM, Ryan E Seelis RE, Rabinovitch A, Rajotte RV. Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 55.
4. Ricordi C, Tzakis AG, Carroll PB, et al. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 1992; 53: 407.
5. I Newsletter 7: International Islet Transplant Registry. Giessen, Germany: Justig-Liebig University, 1997.
6. Korsgren O, Jansson L, Andersson A. Effects of hyperglycemia on function of isolated mouse pancreatic islets transplanted under kidney capsule. Diabetes 1989; 38: 510.
7. Montana-E, Bonner-Weir S, Weir GC. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozotocin diabetic C57BL/6 mice. J Clin Invest 1993; 91: 780.
8. Jansson L, Eizirik DL, Pipeleers DG, Borg LA, Hellerstrom C, Andersson A. Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice. J Clin Invest 1995; 96: 721.
9. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45: 1161.
10. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450.
11. Russell WE, McGowan JA, Bucher NL. Biological properties of a hepatocyte growth factor from rat platelets. J Cell Physiol 1984; 119: 193.
12. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440.
13. Miyazawa K, Tsubouchi H, Naka D, et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967.
14. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995; 345: 293.
15. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60.
16. Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 7001.
17. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901.
18. Furlong RA. The biology of hepatocyte growth factor/scatter factor. Bioessays 1992; 14: 613.
19. Santos OF, Barros EJ, Yang XM, et al. Involvement of hepatocyte growth factor in kidney development. Dev Biol 1994; 163: 525.
20. Schmidt C, Bladt F, Goedecke S, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699.
21. Uehara Y, Minowa O, Mon C, et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995; 373: 702.
22. Niranjan B, Buluwela L, Yant J, et al. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 1995; 121: 2897.
23. Matsumoto K, Nakamura T. Breakthroughs and views: hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997; 239: 639.
24. Ohmichi H, Koshimizu U, Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development 1998; 125: 1315.
25. Kaido T, Yamaoka S, Tanaka J, et al. Continuous HGF supply from HGF-expressing fibroblasts transplanted into spleen prevents CC14-induced acute liver injury in rats. Biochem Biophys Res Commun 1996; 218. 1.
26. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 1998; 244: 683.
27. Kawaida K, Matsumoto K, Shimazu H, Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994; 91: 4357.
28. Miller SB, Martin DR, Kissane J, Hammerman MR. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 1994; 266: F129.
29. Mizuno S, Kurosawa T, Matsumoto K, Mizuno HY, Okamoto M, Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998; 101: 1827.
30. Sutton R, Peters M, McShane P, Gray DWR, Morris PJ. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 1986; 42: 689.
31. Okeda T, Ono J, Takaki R, Todo S. Simple method for the collection of pancreatic islets by the use of Ficoll-Conray gradient. Endocrinol Jpn 1979; 26: 495.
32. Kemp CB, Knight MJ, Scharp DW, Lacy PE, Ballinger WF. Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature 1973; 244: 447.
33. Shimomura T, Miyazawa K, Komiyama Y, et al. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 1995; 229: 257.
34. Zioncheck TF, Richardson L, Liu J, et al. Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J Biol Chem 1995; 270: 16871.
35. Roos F, Ryan Am, Chamow SM, Bennett GL, Schwall RH. Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor. Am J Physiol 1995; 268: G380.
36. Yasunami Y, Lacy PE, Davie JM, Finke EH. Prolongation of islet xenograft survival (rat to mouse) by in vitro culture at 37 °C. Transplantation 1983; 35: 281.
37. Liu K, Kato Y, Narukawa M, et al. Importance of the liver in plasma clearance of hepatocyte growth factor in rats. Am J Physiol 1992; 263: G642.
38. Appasamy R, Tanabe M, Murase N, et al. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest 1993; 68: 270.
39. Zioncheck TF, Richardson L, DeGuzman GG, Modi NB, Hansen SE, Godowski PJ. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology 1994; 134: 1879.
40. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 1993; 268: 10024.
41. Mizuno K, Tanoue Y, Okano I, Harano T, Takada K, Nakamura T. Purification and characterization of hepatocyte growth factor (HGF)-converting enzyme: activation of pro-HGF. Biochem Biophys Res Commun 1994; 198; 1161.
42. Kaufman DB, Gores PF, Field MJ, et al. Effect of 15 deoxyspargualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal mass. Diabetes 1994; 43: 778.
43. Ueki M, Yasunami Y, Motoyama K, Funakoshi A, Ikeda S, Tanaka K. The amelioration of hyperglycemia in streptozotocin-induced diabetic rats after the intraportal transplantation of an insufficient number of islets with nicotinamide treatment. Transplantation 1995; 60: 313.
44. Nagai T, Yasunami Y, Nagata N, Ryu S, Ono J, Ikeda S. Amelioration of hyperglycemia in streptozotocin-induced diabetic rats receiving a marginal mass of islet grafts by an oral antidiabetic agent, troglitazone. Pancreas 1996; 13: 381.
45. Ichiguchi O, Yamaguchi Y, Miyanari N, et al. Enhanced hepatocyte growth factor expression associated with prolonged rat hepatic allograft survival in recipients pretreated with donor specific blood. Transplantation 1999; 67: 115.